View in EDS

The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.

Saved in:
Bibliographic Details
Title: The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.
Authors: Badder LM; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK., Davies JA; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK., Meniel VS; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK., Marušková M; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK., Salvador-Barbero B; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK., Bayliss RJ; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK., Phesse TJ; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia., Hogan C; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK., Parker AL; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK. ParkerAL@cardiff.ac.uk.; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK. ParkerAL@cardiff.ac.uk.
Source: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1694-1706. Date of Electronic Publication: 2024 Oct 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39369056
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The αvβ6 integrin specific virotherapy, Ad5<subscript>NULL</subscript>-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Badder+LM%22">Badder LM</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.<br /><searchLink fieldCode="AU" term="%22Davies+JA%22">Davies JA</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.<br /><searchLink fieldCode="AU" term="%22Meniel+VS%22">Meniel VS</searchLink>; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK.<br /><searchLink fieldCode="AU" term="%22Marušková+M%22">Marušková M</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.<br /><searchLink fieldCode="AU" term="%22Salvador-Barbero+B%22">Salvador-Barbero B</searchLink>; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK.<br /><searchLink fieldCode="AU" term="%22Bayliss+RJ%22">Bayliss RJ</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.<br /><searchLink fieldCode="AU" term="%22Phesse+TJ%22">Phesse TJ</searchLink>; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hogan+C%22">Hogan C</searchLink>; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff, CF24 4HQ, UK.<br /><searchLink fieldCode="AU" term="%22Parker+AL%22">Parker AL</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK. ParkerAL@cardiff.ac.uk.; Systems Immunity University Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK. ParkerAL@cardiff.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1694-1706. <i>Date of Electronic Publication: </i>2024 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39369056
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-024-02869-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1694
    Titles:
      – TitleFull: The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Badder LM
      – PersonEntity:
          Name:
            NameFull: Davies JA
      – PersonEntity:
          Name:
            NameFull: Meniel VS
      – PersonEntity:
          Name:
            NameFull: Marušková M
      – PersonEntity:
          Name:
            NameFull: Salvador-Barbero B
      – PersonEntity:
          Name:
            NameFull: Bayliss RJ
      – PersonEntity:
          Name:
            NameFull: Phesse TJ
      – PersonEntity:
          Name:
            NameFull: Hogan C
      – PersonEntity:
          Name:
            NameFull: Parker AL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1